东曜药业-B(01875)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01875 东曜药业-B

未开盘 07-30 15:59:46

2.740

-0.010

-0.36%

最高2.940	最低2.620	成交量133.32万
今开2.740	昨收2.750	日振幅11.64%
总市值21.17亿	流通市值21.17亿	总股本7.73亿
成交额374.64万	换手率0.17%	流通股本7.73亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01875","market":"HK","secType":"STK","nameCN":"东曜药业-B","latestPrice":2.74,"timestamp":1753862386537,"preClose":2.75,"halted":0,"volume":1333200,"delay":0,"floatShares":772787887,"shares":772787887,"eps":0.05215427058066238,"marketStatus":"未开盘","change":-0.01,"latestTime":"07-30 15:59:46","open":2.74,"high":2.94,"low":2.62,"amount":3746380,"amplitude":0.116364,"askPrice":2.74,"askSize":8400,"bidPrice":2.7,"bidSize":26400,"shortable":0,"etf":0,"ttmEps":0.05215427058066238,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":0,"adr":0,"listingDate":1573142400000,"exchange":"SEHK","adjPreClose":2.75,"openAndCloseTimeList":[[1753839000000,1753848000000],[1753851600000,1753862400000]],"volumeRatio":1.567069,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01875","defaultTab":"news","newsList":[{"id":"2554167769","title":"东曜药业-B(01875)：英文股份简称将更改为“BIODLINK-B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2554167769","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554167769?lang=zh_cn&edition=full","pubTime":"2025-07-25 18:49","pubTimestamp":1753440587,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东曜药业-B(01875)公布，公司用作于联交所买卖股份的英文股份简称将由“TOT BIOPHARM-B”更改为“BIODLINK-B”，自2025年7月30日上午九时正起生效。公司中文股份简称“东曜药业-B”及股份代号“1875”维持不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01875","BK1161","BK1574"],"gpt_icon":0},{"id":"2552212231","title":"东曜药业-B07月16日主力净流入4.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2552212231","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552212231?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:15","pubTimestamp":1752653738,"startTime":"0","endTime":"0","summary":"07月16日，东曜药业-B股价收平报1.90元，成交金额73.0万元，换手率0.05%，振幅1.05%，量比3.40。东曜药业-B今日主力资金净流入4.6万元，上一交易日主力净流出0万元。该股近5个交易日上涨3.26%，主力资金累计净流入4.6万元；近20日主力资金累计净流入4.6万元，其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170332a6ad11ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170332a6ad11ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1161","BK1574"],"gpt_icon":0},{"id":"2547600560","title":"2025东曜药业私董会：让中国方案，成为全球答案！","url":"https://stock-news.laohu8.com/highlight/detail?id=2547600560","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547600560?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:41","pubTimestamp":1751276495,"startTime":"0","endTime":"0","summary":"近日，由东曜药业携手BioPlus、科百特、纳微科技、恒驭生物共同呈现的“创药潮头，并肩出海”私董会在苏州成功举办。未来，东曜药业将以BioDlink为新起点，将持续开放国际化能力池，与行业共拓“创药潮头，并肩出海”的新航海时代——让中国方案，成为全球答案。在质量体系方面，东曜药业质量管","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630174835a4c652b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630174835a4c652b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"2539247200","title":"东曜药业-B05月30日获主力加仓112.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539247200","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539247200?lang=zh_cn&edition=full","pubTime":"2025-05-30 16:15","pubTimestamp":1748592912,"startTime":"0","endTime":"0","summary":"05月30日, 东曜药业-B股价涨4.89%，报收1.93元，成交金额187.2万元，换手率0.13%，振幅4.35%，量比4.19。东曜药业-B今日主力资金净流入112.8万元，上一交易日主力净流入124.3万元。该股近5个交易日上涨6.63%，主力资金累计净流入237.1万元；近20日主力资金累计净流入237.1万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530172552a6f318ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530172552a6f318ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1161","BK1574"],"gpt_icon":0},{"id":"2538420091","title":"东曜药业建议将英文名称更改为“BioDlink International Company”","url":"https://stock-news.laohu8.com/highlight/detail?id=2538420091","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538420091?lang=zh_cn&edition=full","pubTime":"2025-05-28 18:47","pubTimestamp":1748429224,"startTime":"0","endTime":"0","summary":"格隆汇5月28日丨东曜药业(01875.HK)公告，公司建议将公司英文名称由“TOT BIOPHARM International Company Limited”更改为“BioDlink International Company Limited”。更改公司英文名称须经股东于股东周年大会上以特别决议案的方式批准及香港公司注册处处长的相关批准。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505281851499768685d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505281851499768685d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"2537166312","title":"东曜药业取得一种降低交叉污染风险的装载支架专利，降低摆放过程因接触引起的交叉污染风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2537166312","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537166312?lang=zh_cn&edition=full","pubTime":"2025-05-24 09:23","pubTimestamp":1748049786,"startTime":"0","endTime":"0","summary":"金融界2025年5月24日消息，国家知识产权局信息显示，东曜药业有限公司取得一项名为“一种装载支架”的专利，授权公告号CN222893160U，申请日期为2024年07月。专利摘要显示，本实用新型公开了一种装载支架，涉及微生物检测领域。通过天眼查大数据分析，东曜药业有限公司参与招投标项目72次，财产线索方面有商标信息92条，专利信息68条，此外企业还拥有行政许可37个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505240934059500f2b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505240934059500f2b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"2535732039","title":"东曜药业-B第一季度营业收入同比增长13%至2.52亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535732039","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535732039?lang=zh_cn&edition=full","pubTime":"2025-05-13 08:30","pubTimestamp":1747096200,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　东曜药业-B（01875）发布公告，截至2025年3月31日止3个月期间，本集团的营业收入同比增长13%至人民币 2.52亿元，主要系由于自研产品收入稳步增长。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-13/doc-inewkmnk2276873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01875"],"gpt_icon":0},{"id":"2534208735","title":"港股公告掘金 | 宁德时代今日起招股 发售价将不高于263港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534208735","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534208735?lang=zh_cn&edition=full","pubTime":"2025-05-12 23:02","pubTimestamp":1747062136,"startTime":"0","endTime":"0","summary":"【重大事项】宁德时代(03750)拟全球发售1.18亿股H股 引入中石化(香港)作为基石投资者石药集团(01093)：富马酸伏诺拉生片获药品注册批件远大医药(00512)创新放射性核素偶联药物 TLX591-CDx 中国 III 期临床研究完成全部患者入组给药并计划今年内递交上市申请荣昌生物(09995)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点复星医药(02196","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","LU2097828805.USD","01875","LU1152091168.USD","LU0359201885.HKD","LU2348773727.SGD","IE00BZ08YT58.USD","BK1589","BK4519","LU0302445910.USD","LU1934453819.USD","LU0823414551.USD","BK1608","LU0572944931.SGD","IE0003795394.USD","IE0003851619.USD","EVS.SI","LU0516422440.USD","LU0651947912.USD","LU0516423091.SGD","LU2476274720.SGD","LU1861214812.USD","LU0823414478.USD","LU0871576103.HKD","03750","LU2275660780.HKD","LU1719994722.HKD","SGXZ49509284.SGD","SGXZ81163826.USD","JKS","LU0132412106.USD","SG9999002828.SGD","LU1997244956.HKD","LU0228659784.USD","LU1720050803.USD","LU2424517915.HKD","LU2148510915.USD","LU0269904917.USD","90132","01093","LU0039217434.USD","LU1515016050.SGD","YANG","LU1226287875.USD","02382","HSTECH","LU0029875118.USD"],"gpt_icon":1},{"id":"2534522402","title":"东曜药业一季度营收同比增13% 净利润降至209万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534522402","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534522402?lang=zh_cn&edition=full","pubTime":"2025-05-12 20:05","pubTimestamp":1747051500,"startTime":"0","endTime":"0","summary":"5月12日，东曜药业（01875）发布公告，截止2025年3月31日的三个月内，公司营业收入同比增长13%至2.52亿元。公司在此期间实现净利润209万元，而去年同期为741万元，显示出利润的下降。综合收益总额为255万元，较去年同期的825万元有所减少。在财务状况方面，截至2025年3月31日，公司流动资产为7.3亿元，非流动资产为7.43亿元，流动负债为3.48亿元，非流动负债为3.92亿元。公司的净资产总额为7.33亿元。（文章来源：财中社）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051220073794f46f97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051220073794f46f97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875"],"gpt_icon":0},{"id":"2534976225","title":"东曜药业-B(01875)第一季度营业收入同比增长13%至2.52亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534976225","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534976225?lang=zh_cn&edition=full","pubTime":"2025-05-12 19:03","pubTimestamp":1747047828,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东曜药业-B(01875)发布公告，截至2025年3月31日止3个月期间，本集团的营业收入同比增长13%至人民币 2.52亿元，主要系由于自研产品收入稳步增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"东曜药业-B(01875)第一季度营业收入同比增长13%至2.52亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01875"],"gpt_icon":0},{"id":"1194576384","title":"港股生物医药B类股逆势活跃，歌礼制药-B涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194576384","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194576384?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:11","pubTimestamp":1744683073,"startTime":"0","endTime":"0","summary":"港股异动｜生物医药B类股逆势活跃，$歌礼制药-B(01672)$涨超8%，$华领医药-B(02552)$、$东曜药业-B(01875)$涨近5%，$迈博药业-B(02181)$涨超4%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","BK1161","BK4614","01672","BK1574","02552","02181","YANG","BK1191","01875","BK1515","HSTECH","07226","01477"],"gpt_icon":0},{"id":"1180591335","title":"港股生物医药B类股表现强势，云顶新耀-B涨近13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180591335","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180591335?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:45","pubTimestamp":1741315530,"startTime":"0","endTime":"0","summary":"港股异动｜生物医药B类股表现强势，$云顶新耀-B(01952)$涨近13%，$心通医疗-B(02160)$涨近10%，$腾盛博药-B(02137)$涨近8%，$东曜药业-B(01875)$涨6%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02160","BK1161","BK1574","BK1100","BK1587","01952","HSTECH","07226","YANG","HSCEI","02137","01875"],"gpt_icon":0},{"id":"2517362241","title":"东曜药业-B03月06日主力净流入58万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517362241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517362241?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:17","pubTimestamp":1741249023,"startTime":"0","endTime":"0","summary":"03月06日, 东曜药业-B股价涨9.89%，报收2.00元，成交金额97万元，换手率0.07%，振幅10.99%，量比3.21。东曜药业-B今日主力资金净流入58万元，上一交易日主力净流出0万元。该股近5个交易日上涨12.36%，主力资金累计净流入58万元；近20日主力资金累计净流入5万元，其中净流入天数为2日。该股主力净额占比0.04%，港股市场排名275/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170113a2622beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170113a2622beb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"2516676952","title":"乐普生物创新药上市遇阻，合作方东曜药业“躺枪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2516676952","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516676952?lang=zh_cn&edition=full","pubTime":"2025-03-04 21:06","pubTimestamp":1741093578,"startTime":"0","endTime":"0","summary":"简而言之便是，东曜药业紧急辟谣称，乐普生物主动撤回MRG003的新药上市申请，与其没有关系——与东曜药业所承担的相关工作完成情况及质量无关。股价大跌之后，今日上午，乐普生物随即发布公告回应新药上市不顺利的原因。不过，在乐普生物MRG003事件中，最滑稽一幕在于，和当事人乐普生物相比，东曜药业的身份是其第三方，企业在盘后紧急的紧急发言撇清关系也显示了其求生欲之强。不过，在2024年上半年，卖药依旧是东曜药业的主业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304211157a25eebe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304211157a25eebe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","01875","BK1574","02157","BK1161"],"gpt_icon":0},{"id":"2514875242","title":"东曜药业-B02月27日遭主力抛售29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514875242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514875242?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:15","pubTimestamp":1740644112,"startTime":"0","endTime":"0","summary":"02月27日, 东曜药业-B股价跌3.26%，报收1.78元，成交金额64万元，换手率0.05%，振幅6.52%，量比1.52。东曜药业-B今日主力资金净流出29万元，上一交易日主力净流出4万元。该股近5个交易日上涨1.71%，主力资金累计净流出14万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出53万元，其中净流出天数为4日。该股主力净额占比0.02%，港股市场排名2408/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227170756a2561452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227170756a2561452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2512146092","title":"东曜药业-B盘中异动 早盘股价大涨5.88%报1.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512146092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512146092?lang=zh_cn&edition=full","pubTime":"2025-02-19 10:42","pubTimestamp":1739932940,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘10时42分，东曜药业-B股票出现异动，股价快速拉升5.88%。截至发稿，该股报1.800港元/股，成交量4000股，换手率0.00%，振幅5.88%。东曜药业-B股票所在的生物技术行业中，整体涨幅为0.55%。东曜药业-B公司简介：东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219104220a24b4c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219104220a24b4c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1574","BK1161"],"gpt_icon":0},{"id":"2512490212","title":"东曜药业-B盘中异动 股价大涨5.26%报1.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512490212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512490212?lang=zh_cn&edition=full","pubTime":"2025-02-18 10:52","pubTimestamp":1739847151,"startTime":"0","endTime":"0","summary":"2025年02月18日早盘10时52分，东曜药业-B股票出现波动，股价急速上涨5.26%。截至发稿，该股报1.800港元/股，成交量2400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入4320港元，流出0港元。东曜药业-B股票所在的生物技术行业中，整体涨幅为0.83%。东曜药业-B公司简介：东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502181052319626ee8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502181052319626ee8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2512940129","title":"东曜药业-B盘中异动 下午盘股价大跌5.00%报1.710港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512940129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512940129?lang=zh_cn&edition=full","pubTime":"2025-02-17 13:29","pubTimestamp":1739770148,"startTime":"0","endTime":"0","summary":"2025年02月17日下午盘13时29分，东曜药业-B股票出现异动，股价急速下挫5.00%。截至发稿，该股报1.710港元/股，成交量5200股，换手率0.00%，振幅0.00%。东曜药业-B股票所在的生物技术行业中，整体跌幅为0.34%。东曜药业-B公司简介：东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217132908abd1c8d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217132908abd1c8d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"2510005842","title":"东曜药业-B盘中异动 早盘股价大涨5.88%报1.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510005842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510005842?lang=zh_cn&edition=full","pubTime":"2025-02-10 10:49","pubTimestamp":1739155766,"startTime":"0","endTime":"0","summary":"2025年02月10日早盘10时49分，东曜药业-B股票出现异动，股价快速上涨5.88%。截至发稿，该股报1.800港元/股，成交量19.96万股，换手率0.03%，振幅5.88%。资金方面，该股资金流入10.2808万港元，流出23.9868万港元。东曜药业-B股票所在的生物技术行业中，整体跌幅为1.04%。东曜药业-B公司简介：东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210104926961d5daf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210104926961d5daf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1574","BK1161"],"gpt_icon":0},{"id":"2508711885","title":"东曜药业-B（01875.HK）2月3日收盘下跌3.16%，成交5.08万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508711885","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508711885?lang=zh_cn&edition=full","pubTime":"2025-02-03 17:08","pubTimestamp":1738573722,"startTime":"0","endTime":"0","summary":"2月3日，截至港股收盘，恒生指数下跌0.04%，报20217.26点。东曜药业-B收报1.84港元/股，下跌3.16%，成交量2.76万股，成交额5.08万港元，振幅0.0%。最近一个月来，东曜药业-B累计涨幅5.56%，今年来累计涨幅6.15%，跑赢恒生指数0.82%的涨幅。财务数据显示，截至2024年6月30日，东曜药业-B实现营业总收入5.21亿元，同比增长58.69%；归母净利润3155.9万元，同比增长308.13%；毛利率72.4%，资产负债率50.3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/03170847938909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01875","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.totbiopharm.com.cn","stockEarnings":[{"period":"1week","weight":0.2804},{"period":"1month","weight":0.398},{"period":"3month","weight":0.4731},{"period":"6month","weight":0.4421},{"period":"1year","weight":0.4346},{"period":"ytd","weight":0.5307}],"compareEarnings":[{"period":"1week","weight":-0.0141},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.1382},{"period":"6month","weight":0.2448},{"period":"1year","weight":0.4807},{"period":"ytd","weight":0.2551}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东曜药业于2019年在香港联交所主板上市，2021年全面转型，致力于成为全球药物开发领域专业CDMO合作伙伴，提供生物药开发到生产一站式解决方案。\n公司拥有从研发、工艺开发、临床试验、注册报批到商业化生产的全流程经验，建立了完整的ADC技术平台，具备核心偶联工艺和放大的技术优势，以及ADC关键质量属性的自主分析能力，保证产品高质量开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.065981},{"month":2,"riseRate":0,"avgChangeRate":-0.043389},{"month":3,"riseRate":0.5,"avgChangeRate":-0.024422},{"month":4,"riseRate":0.833333,"avgChangeRate":0.069994},{"month":5,"riseRate":0.666667,"avgChangeRate":0.07905},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.001367},{"month":7,"riseRate":0.333333,"avgChangeRate":0.039791},{"month":8,"riseRate":0.2,"avgChangeRate":-0.035294},{"month":9,"riseRate":0.6,"avgChangeRate":0.009074},{"month":10,"riseRate":0.4,"avgChangeRate":-0.026839},{"month":11,"riseRate":0,"avgChangeRate":-0.055792},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.018325}],"exchange":"SEHK","name":"东曜药业-B","nameEN":"TOT BIOPHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东曜药业-B(01875)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东曜药业-B(01875)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东曜药业-B,01875,东曜药业-B股票,东曜药业-B股票老虎,东曜药业-B股票老虎国际,东曜药业-B行情,东曜药业-B股票行情,东曜药业-B股价,东曜药业-B股市,东曜药业-B股票价格,东曜药业-B股票交易,东曜药业-B股票购买,东曜药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东曜药业-B(01875)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东曜药业-B(01875)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}